Harvest Group Wealth Management’s AtriCure ATRC Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2023
Q1
$912 Buy
22
+6
+38% +$249 ﹤0.01% 153
2022
Q4
$710 Hold
16
– – ﹤0.01% 162
2022
Q3
$1K Hold
16
– – ﹤0.01% 129
2022
Q2
$1K Buy
+16
New +$758 ﹤0.01% 141

Other funds holding ATRC

Harvest Group Wealth Management's ATRC Position: Q1 2023 in Review

Harvest Group Wealth Management increased its AtriCure (ATRC) stake by 38% in Q1 2023, buying an estimated $249 and bringing the position to 22 shares worth $912. The position accounts for ﹤0.01% of the portfolio, ranked #153.

Harvest Group Wealth Management first reported a position in ATRC in Q2 2022 and has held it in 4 quarters since. The position peaked at $1K in Q3 2022. 224 funds tracked by Wall St. Rank hold ATRC as of Q1 2023.

  • Harvest Group Wealth Management held 22 shares of AtriCure worth $912 as of Q1 2023.
  • Harvest Group Wealth Management bought 6 AtriCure shares in Q1 2023, an estimated $249.
  • AtriCure made up ﹤0.01% of Harvest Group Wealth Management's portfolio in Q1 2023, its #153 holding.
  • Harvest Group Wealth Management first reported a position in AtriCure in Q2 2022 and has held it in 4 quarters since.
  • Harvest Group Wealth Management's AtriCure position peaked at $1K in Q3 2022.
  • 224 funds tracked by Wall St. Rank held AtriCure as of Q1 2023.

Based on Harvest Group Wealth Management's 13F filing for Q1 2023, filed 28 Apr 2023.